Download This Bill in Microsoft Word format
Indicates Matter Stricken
Indicates New Matter
S. 907
STATUS INFORMATION
General Bill
Sponsors: Senators Grooms, Verdin and Garrett
Document Path: l:\s-res\lkg\035medi.kmm.lkg.docx
Companion/Similar bill(s): 4568
Introduced in the Senate on December 6, 2021
Currently residing in the Senate
Summary: Abortion
HISTORY OF LEGISLATIVE ACTIONS
Date Body Action Description with journal page number
-------------------------------------------------------------------------------
12/6/2021 Senate Introduced and read first time (Senate Journal-page 21)
12/6/2021 Senate Referred to Committee on Medical Affairs
(Senate Journal-page 21)
3/10/2022 Senate Polled out of committee Medical Affairs
(Senate Journal-page 7)
3/10/2022 Senate Committee report: Favorable Medical Affairs
(Senate Journal-page 7)
View the latest legislative information at the website
VERSIONS OF THIS BILL
POLLED OUT OF COMMITTEE
March 10, 2022
S. 907
S. Printed 3/10/22--S.
Read the first time December 6, 2021.
To whom was referred a Bill (S. 907) to amend Article 1, Chapter 41, Title 44 of the 1976 Code, relating to abortions, by adding Section 44-41-90 to require the disclosure of medical, etc., respectfully
Has polled the Bill out of committee without report.
TO AMEND ARTICLE 1, CHAPTER 41, TITLE 44 OF THE 1976 CODE, RELATING TO ABORTIONS, BY ADDING SECTION 44-41-90 TO REQUIRE THE DISCLOSURE OF MEDICAL INFORMATION TO PERSONS WHO MAY RECEIVE A CHEMICALLY INDUCED ABORTION, WITH EXCEPTIONS.
Be it enacted by the General Assembly of the State of South Carolina:
SECTION 1. Article 1, Chapter 41, Title 44 of the 1976 Code is amended by adding:
"Section 44-41-90. (A) When mifepristone is administered, dispensed, or otherwise provided to a pregnant woman by a physician or any person acting under the physician's direction, whether in a licensed clinic, private medical office, or any other facility, the physician or the person acting under the physician's direction shall provide the disclosure statement set forth in subsection (B) to the pregnant woman. The disclosure statement may be provided by doing any of the following:
(1) stapling the disclosure statement to a bag, envelope, or other package that contains misoprostol for the pregnant woman to self-administer at home;
(2) attaching the disclosure statement to a written prescription for misoprostol provided by the physician or the person acting under the physician's direction; or
(3) attaching the disclosure statement to the patient's discharge instructions if the prescription for misoprostol is sent directly to a pharmacy.
(B) The disclosure statement required by this section must contain all of the following text: 'PLEASE READ BEFORE TAKING SECOND PILL: Research has indicated that the first pill provided, identified as mifepristone, is not always effective in ending a pregnancy. If, after taking the first pill, you would like to change your decision, please consult a physician or health care provider immediately to determine whether there are options available to assist you in continuing your pregnancy. Medication is also available by prescription to help restore progesterone and potentially strengthen the pregnancy if you and your physician make that decision.'
(C)(1) Nothing in this section may be construed as creating or recognizing a right to abortion.
(2) Nothing in this section may be construed as requiring the disclosure statement to be provided to a woman facing a spontaneous miscarriage as defined in Section 44-41-610.
(3) Nothing in this section may be construed as requiring a pharmacy or any entity other than the facility where the abortion is administered to provide the disclosure statement.
(D) As used in this section:
(1) 'Abortion pill' means the use of mifepristone or misoprostol to induce chemical abortion.
(2) 'Mifepristone' means a synthetic steroid that inhibits the action of progesterone, given orally in early pregnancy to induce a chemical abortion. Mifepristone is the first drug used in a two-drug process to induce a chemical abortion.
(3) 'Misoprostol' means a synthetic prostaglandin E1 analogue that is used to induce a chemical abortion. Misoprostol is the second drug used in a two-drug process to induce a chemical abortion."
SECTION 2. If any section, subsection, paragraph, subparagraph, sentence, clause, phrase, or word of this act is for any reason held to be unconstitutional or invalid, then such holding shall not affect the constitutionality or validity of the remaining portions of this act, the General Assembly hereby declaring that it would have passed this act, and each and every section, subsection, paragraph, subparagraph, sentence, clause, phrase, and word thereof, irrespective of the fact that any one or more other sections, subsections, paragraphs, subparagraphs, sentences, clauses, phrases, or words hereof may be declared to be unconstitutional, invalid, or otherwise ineffective.
SECTION 3. This act takes effect upon approval by the Governor.
This web page was last updated on March 11, 2022 at 9:12 AM